Gyeonggi-do, South Korea

Hwan Cho, Ii

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hwan Cho, Ii: Innovator in Neurological Treatments

Introduction

Hwan Cho, Ii is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. His innovative work has led to the development of a unique compound that holds promise for medical applications.

Latest Patents

Hwan Cho, Ii holds a patent for a quinazoline-2,4-dione derivative, which is described in his invention titled "Quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same." This invention relates to a novel quinazoline-2,4-dione derivative of formula (I), a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising a compound of formula (I) as an active ingredient for preventing or treating neurological brain disease. He has 1 patent to his name.

Career Highlights

Throughout his career, Hwan Cho, Ii has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Shin Poong Pharmaceutical Co., Ltd. and Solum Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Hwan Cho, Ii has collaborated with several professionals in his field, including Eun Bang Lee and Sin Cheol Kang. These partnerships have likely enhanced his research and development efforts, leading to advancements in neurological treatments.

Conclusion

Hwan Cho, Ii is a distinguished inventor whose work in the pharmaceutical industry has the potential to impact the treatment of neurological diseases significantly. His innovative contributions and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…